Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

Haemonetics Corporation (HAE) 0.00 0.41
Price Open:42.44Day's Range:37.71000 - 82.98000
Price Close:42.3052wk Range:37.71000 - 82.98000
Price Day Change:0.41Volume:523,416
Price % Change:0.97Market Cap:2.181B
Bid:42.32000PE Ratio:57.16
Ask:0.00000EPS Diluted:0.74
Trade HAE NOW!

The Latest On HAE

Benzinga's Top Initiations 6/6/13 8:33am
UPDATE: Goldman Sachs Initiates Haemonetics at Neutral on Stable Outlook 5/31/13 9:25am
Benzinga's Top Initiations 5/31/13 7:52am
Mid-Afternoon Market Update: RIMM Falls Further, Endo Health Rises on Exploration of a Sale 1/30/13 4:22pm
Mid-Day Market Update: BlackBerry 10 Release Sends Shares Lower, Isis Pharma Boosts 1/30/13 2:34pm
Allscripts Axes CEO, Ends Plans to Sell Itself 12/20/12 3:54pm
Haemonetics Effects 2-for-1 Stock Split 12/3/12 9:02am
UPDATE: Benchmark Initiates Haemonetics Corporation at Buy on Organic Growth 9/13/12 12:02pm
Benzinga's Top Initiations 9/13/12 7:31am
Small-Cap Corner: A Forgotten Biotech ETF 7/5/12 6:11pm
Benzinga's Top Upgrades with Color for May 1, 2012 5/1/12 10:15am
UPDATE: Morgan Stanley Upgrades Haemonetics; Removes PT 5/1/12 8:41am
more
Press Releases
Haemonetics to Present at The William Blair 33rd Annual Growth Stock Conference 6/5/13 Newswire
Haemonetics And SABM Announce Research Grant 5/29/13 Newswire
Haemonetics to Present at The Jefferies 2013 Global Healthcare Conference 5/24/13 Newswire
Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference 5/23/13 Newswire
Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidance 5/1/13 Newswire
Haemonetics Completes Hemerus Medical, LLC Acquisition 5/1/13 Newswire
Haemonetics Sets Date for Investor/Analyst Meeting 4/24/13 Newswire
Haemonetics Sets Date for Fourth Quarter Fiscal Year 2013 Earnings Release: Wednesday, May 1, 2013 4/1/13 Newswire
Haemonetics to Present at The Raymond James Institutional Investors Conference 2/25/13 Newswire
Haemonetics' CMO, Mark Popovsky, Joins U.S. Health and Human Services Advisory Committee on Blood Safety 2/14/13 Newswire
Haemonetics to Present at Citi 2013 Global Healthcare Conference 2/13/13 Newswire
Haemonetics to Present at Leerink Swann 2013 Global Healthcare Conference 2/6/13 Newswire

Get the latest HAE stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Haemonetics Corporation stock price.

Partner Headlines
BSX Commences U.S. INTREPID Trial - Analyst Blog 6/18/13
German Court Rules in Favor of MDT - Analyst Blog 6/17/13
Positive Data for COV's Solitaire - Analyst Blog 6/17/13
LIFE Continues Korean Expansion - Analyst Blog 6/14/13
FDA Nod for STJ's Ellipse & Assura - Analyst Blog 6/13/13
CardioNet Skyrockets on New Deal - Analyst Blog 6/12/13
Zimmer Stays at Neutral - Analyst Blog 6/11/13
Qiagen Attempts to Expand NGS Platform - Analyst Blog 6/11/13
Symmetry Provides Dismal 2013 View - Analyst Blog 6/11/13
Life Expands Portfolio - Analyst Blog 6/11/13
Quest Scans 2Q; Maintains FY13 View - Analyst Blog 6/10/13
Edwards Lowered to Underperform - Analyst Blog 6/10/13